Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results

Eurosurveillance

Volumn 20, Issue 36, 2015, Pages

  Pebody, R ^a   Warburton, F ^a   Andrews, N ^a   Ellis, J ^a   Von Wissmann, B ^b   Robertson, C ^c   Yonova, I ^d,e   Cottrell, S ^f   Gallagher, N ^g   Green, H ^a   Thompson, C ^a   Galiano, M ^a   Marques, D ^b   Gunson, R ^b   Reynolds, A ^b   Moore, C ^f   Mullett, D ^d,e   Pathirannehelage, S ^d,e   Donati, M ^a   Johnston, J ^g   De Lusignan, S ^d,e   McMenamin, J ^b   Zambon, M ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d RCGP Research and Surveillance Centre   (United Kingdom)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f PUBLIC HEALTH WALES   (United Kingdom)

^g PUBLIC HEALTH AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; GENE SEQUENCE; HEALTH PROGRAM; HUMAN; INFLUENZA A (H3N2); INFLUENZA B VIRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYLOGENETIC TREE; PRIMARY HEALTH CARE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; UNITED KINGDOM; VACCINATION; ADOLESCENT; CHILD; GENETICS; GREAT BRITAIN; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; LABORATORY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASON; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LABORATORIES; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEASONS; SENTINEL SURVEILLANCE; VACCINATION; YOUNG ADULT;

EID: 84965093931     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.36.30013     Document Type: Article

References (20)

1. Department of Health. Public Health England (PHE). The national flu immunisation programme 2014/15. London: PHE. 28 Apr 2014. Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/316007/ FluImmunisationLetter2014_accessible.pdf
2. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Geneva: WHO. 20 Feb 2014. Available from: http://www.who.int/influenza/vaccines/virus/ recommendations/2014_15_north/en/
3. Public Health England (PHE). Surveillance of influenza and other respiratory viruses in the United Kingdom: winter 2014 to 2015. Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/429617/ Annualreport_March2015_ver4.pdf
4. BrobergE, SnackenR, AdlhochC, BeauteJ, GalinskaM, PereyaslovD, et al. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill. 2015;20(4):21023. DOI: 10.2807/1560-7917.ES2015.20.4.21023 PMID: 25655052
5. PebodyRG, WarburtonF, EllisJ, AndrewsN, ThompsonC, von WissmannB, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill. 2015;20(5):21025. DOI: 10.2807/1560- 7917.ES2015.20.5.21025 PMID: 25677050
6. AndrewsN, McMenaminJ, DurnallH, EllisJ, LackenbyA, RobertsonC, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill. 2014;19(27):20851. DOI: 10.2807/1560- 7917.ES2014.19.27.20851 PMID: 25033051
7. CurranMD, EllisJS, WreghittTG, ZambonMC. Establishment of a UK National Influenza H5 Laboratory Network.J Med Microbiol. 2007;56(10):1263-7. DOI: 10.1099/jmm.0.47336-0 PMID: 17893159
8. EllisJ, IturrizaM, AllenR, BerminghamA, BrownK, GrayJ, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 2009;14(22):19230. PMID: 19497254
9. GunsonR, MacleanA, DaviesE, BennettS, MillerR, CarmanWF. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus.J Virol Methods. 2010;163(2):258-61. DOI: 10.1016/j.jviromet.2009.10.006 PMID: 19854220
10. GalianoM, AgapowP-M, ThompsonC, PlattS, UnderwoodA, EllisJ, et al. Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS ONE. 2011;6(8):e23779. DOI: 10.1371/journal.pone.0023779 PMID: 21887318
11. MatrosovichM, MatrosovichT, CarrJ, RobertsNA, KlenkHD. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.J Virol. 2003;77(15):8418-25. DOI: 10.1128/ JVI.77.15.8418-8425.2003 PMID: 12857911
12. Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313.
13. ZhouB, DonnellyME, ScholesDT, St GeorgeK, HattaM, KawaokaY, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza A viruses. J Virol. 2009;83(19):10309-13. DOI: 10.1128/JVI.01109-09 PMID: 19605485
14. Centers for Disease Control and Prevention,FlanneryB, ClippardJ, ZimmermanRK, NowalkMP, JacksonML, JacksonLA, et al. . Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5.PMID: 25590680
15. SkowronskiDM, ChambersC, SabaiducS, De SerresG, DickinsonJA, WinterAL, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill. 2015;20(4):21022. DOI: 10.2807/1560-7917. ES2015.20.4.21022 PMID: 25655053
16. HardelidP, FlemingDM, AndrewsN, BarleyM, DurnallH, MangtaniP, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine. 2012;30(7):1371-8. DOI: 10.1016/j.vaccine.2011.12.038 PMID: 22178524
17. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2015-2016 northern hemisphere influenza season. Geneva: WHO. 26 Feb 2015. Available from: http://www.who.int/influenza/vaccines/virus/ recommendations/2015_16_north/en/
18. Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunisation Practice (ACIP). Update on Live Attenuated Influenza Vaccine (LAIV). Atlanta: CDC. 25 Feb 2015. Available from: http://www.cdc.gov/vaccines/acip/meetings/ downloads/slides-2015-02/flu-02-Coelingh.pdf
19. NicholKL, MendelmanPM, MallonKP, JacksonLA, GorseGJ, BelsheRB, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282(2):137-44. DOI: 10.1001/jama.282.2.137 PMID: 10411194
20. GlezenWP, GaglaniMJ, KozinetzCA, PiedraPA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.J Infect Dis. 2010;202(11):1626-33. DOI: 10.1086/657089 PMID: 21028955